MedPath

Retrospective study comparing radiofrequency ablation and proton beam therapy for treatment naive solitary hepatocellular carcinoma: a propensity score analysis

Not Applicable
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000034661
Lead Sponsor
niversity of Tsukuba, Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1) Having extrahepatic lesions. 2) Previously treated with percutaneous ethanol injection therapy 3) Total bilirubin is more than 3.0 mg/d

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival (Five-year overall survival rate)
Secondary Outcome Measures
NameTimeMethod
ocal control period (Five-year Local control rate), progression free survival (Five-year progression free survival rate), Adverse event
© Copyright 2025. All Rights Reserved by MedPath